Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lifecare ASAFRA:LFC0 -15.54%8 Cash Ratio is 0.96 as of Mar. 2026, which is 62% below its 10-year median of 2.52. GuruFocus rates FRA:LFC0 with a GF Score™ of 8/100 and a GF Value™ of €0.01 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 825 Medical Devices & Instruments companies, Lifecare ASA ranks better than 50.55% on this metric.
Lifecare ASA has a Cash Ratio of 0.96. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Lifecare ASA's Cash Ratio or its related term are showing as below:
FRA:LFC0'
s Cash Ratio Range Over the Past 10 Years
Min: 0.06 Med: 2.52 Max: 62.23
Current: 0.96
During the past 11 years, Lifecare ASA's highest Cash Ratio was 62.23. The lowest was 0.06. And the median was 2.52.
FRA:LFC0's Cash Ratio is ranked better than 50.55% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 0.95
vs FRA:LFC0: 0.96
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Lifecare ASA Cash Ratio Related Terms
Lifecare ASA Cash Ratio Historical Data
* Premium members only.
The historical data trend for Lifecare ASA's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lifecare ASA's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecare ASA Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Lifecare ASA's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecare ASA (FRA:LFC0) has a Cash Ratio of 0.96 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Lifecare ASA and its competitors. This is 62% below median its historical median of 2.52. Over the past decade, Lifecare ASA's Cash Ratio has ranged from 0.06 to 62.23. According to the industry distribution chart, Lifecare ASA ranks #408 out of 825 companies in the Medical Devices & Instruments industry, placing it in the top 49.5%.
Is Lifecare ASA's Cash Ratio too high?
Lifecare ASA's current Cash Ratio of 0.96 is 62% below median its 10-year median of 2.52. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 62.23. The Medical Devices & Instruments industry median Cash Ratio is 0.95. Lifecare ASA's value of 0.96 is 1.1% above this industry median. Based on the distribution chart, Lifecare ASA ranks #408 out of 825 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lifecare ASA has a GF Score™ of 8/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's Cash Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #408 out of 825 companies for Cash Ratio. This puts Lifecare ASA in the upper half of its industry. The industry median Cash Ratio is 0.95. Lifecare ASA's value of 0.96 is 1.1% above this benchmark. Historically, Lifecare ASA's own Cash Ratio has ranged from 0.06 to 62.23 over the past decade. While the company's 10-year median is 2.52 vs. the industry median of 0.95, Lifecare ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.95, based on 825 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lifecare ASA's current Cash Ratio of 0.96 is 1.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Lifecare ASA and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecare ASA's current Cash Ratio is 0.96, which is 62% below median its own 10-year median of 2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (FRA:LFC0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.02 — trading 112% above its estimated fair value. The current Cash Ratio is 0.96, which is 62% below median its 10-year median of 2.52 and 1.1% above the Medical Devices & Instruments industry median of 0.95. Lifecare ASA's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Lifecare ASA (FRA:LFC0), the current Cash Ratio is 0.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecare ASA (FRA:LFC0) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecare ASA stock appears to be overvalued.
The current stock price of €0.02 is trading 112% above its estimated GF Value™ of €0.01.
GuruFocus considers Lifecare ASA to be Possible Value Trap.
Key valuation signals for FRA:LFC0:
Cash Ratio: 0.96 (62% below median its 10-year median of 2.52)
GF Value™: €0.01 vs. price of €0.02 (112% above fair value)
Industry Position: 1.1% above the Medical Devices & Instruments median (#408 of 825)
No single metric tells the full story. See the FRA:LFC0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
8GF Score
Get the complete analysis for FRA:LFC0
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LFC0 has been successfully added to your 
